SENATE ADOPTS HATCH PRODUCT LIABILITY PROVISIONS INTO FDA REFORM BILL;WELLSTONE PHARMACOECONOMIC REPORT AMENDMENT ALSO INCLUDED IN SENATE BILL
Executive Summary
Manufacturers would be protected from the presumption that an adverse event report to FDA represents an acknowledgment of liability under an amendment added to the Senate FDA reform bill (S 830) adopted prior to passage of the bill Sept. 24.